MwanzoSHTDY • OTCMKTS
Sinopharm Group ADR
$ 13.01
27 Sep, 20:10:00 GMT -4 · USD · OTCMKTS · Kanusho
Hisa zinazouzwa Marekani
Bei iliyotangulia
$ 12.22
Bei za siku
$ 12.75 - $ 13.08
Bei za mwaka
$ 10.13 - $ 16.31
Thamani ya kampuni katika soko
63.19B HKD
Wastani wa hisa zilizouzwa
elfu 44.99
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(CNY)Jun 2024Mabadiliko Tangu Mwaka Uliopita
Mapato
-122.51B-0.93%
Matumizi ya uendeshaji wa biashara
-6.47B-5.44%
Mapato halisi
-419.63M30.73%
Kiwango cha faida halisi
0.34-32.00%
Mapato kwa kila hisa
EBITDA
-2.33B20.26%
Asilimia ya kodi ya mapato
26.07%
Jumla ya mali
Jumla ya dhima
(CNY)Jun 2024Mabadiliko Tangu Mwaka Uliopita
Uwekezaji wa pesa taslimu na vipindi vifupi
8.62B-74.94%
Jumla ya mali
33.55B-91.97%
Jumla ya dhima
15.61B-94.87%
Jumla ya hisa
17.94B
hisa zilizosalia
3.12B
Uwiano wa bei na thamani
2.36
Faida inayotokana na mali
-2.64%
Faida inayotokana mtaji
-5.30%
Mabadiliko halisi ya pesa taslimu
(CNY)Jun 2024Mabadiliko Tangu Mwaka Uliopita
Mapato halisi
-419.63M30.73%
Pesa kutokana na shughuli
46.42B14.53%
Pesa kutokana na uwekezaji
-362.06M22.79%
Pesa kutokana na ufadhili
-23.30B-6.05%
Mabadiliko halisi ya pesa taslimu
22.75B25.76%
Mtiririko huru wa pesa
103.16B370.65%
Kuhusu
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical. Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted. Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Ilianzishwa
2003
Wafanyakazi
113,635
Tafuta
Futa utafutaji
Funga kisanduku cha kutafutia
Programu za Google
Menyu kuu